Inhibition of pancreatic lipase
US9402858B2 · kind B2 · utility
0Cited by
8References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 25, 2010 |
| Grant date | Aug 2, 2016 |
| Priority date | — |
| Expiry date | Oct 8, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides the use of an alginate Io inhibit pancreatic lipase. The use may be directed to the control of weight in animals including human beings. Preferably the fraction of guluronate dimers in the alginate is at least 0.5.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.